Commercialisation Revenue definition

Commercialisation Revenue means the gross proceeds arising directly from the Commercialisation of IP by the University and actually received in available cash funds by the University in consideration for the grant of a right to Commercialise IP, not including any amounts received which are in consideration for other obligations such as CCR, the conduct of contract or collaborative research or development, or other expenditure obligations, and less all taxes forming part of such amounts.
Sample 1Sample 2Sample 3
Commercialisation Revenue means monies received from the commercialisation of intellectual property. It includes but is not limited to: • royalty payments from licensing of IP• royalty payments from sub-licensing of IP• one-off payments from licensing IP, be these in full or part payment for rights to use IP• proceeds from the outright sale of the IP• milestone payments• minimum performance payments• dividends from shares owned by Lincoln in a company to which it grants a license for the use of IP• proceeds of sale of shares owned by Lincoln in a company to which it grants a license for the use of IP Commercialisation Revenue does not include the overhead component of research funds paid pursuant to a research agreement.
Sample 1Sample 2
Commercialisation Revenue means the gross revenue actually received and retained by the University from the Commercial Exploitation of Intellectual Property, after the payment of any withholding, goods and services or other taxes, bank fees, transaction fees and other charges. Commercialisation Revenue does not include income received from the provision of research, consultancy or other services and does not include any income derived from the delivery of the University’s fee-paying courses, including courses delivered collaboratively with third party educational institutions in Australia or internationally.
Sample 1

Examples of Commercialisation Revenue in a sentence

  • For the avoidance of doubt income from industry sponsored programmes does not fall under the definition of IP Commercialisation Revenue and the cost of the time commitment by ORI staff to support for the IP commercialisation process shall not be considered a vouchable expense.

  • Creators at the University of Melbourne therefore do not receive Commercialisation Revenue from the University of Melbourne, but instead pay to the University of Melbourne a royalty referrable to any Commercialisation they undertake of their own IP.

  • Ownerships Proportions is a term defined in clause 1.1, and is used to determine the proportion of Commercialisation Revenue that is disbursed to the licensing joint owner under clause 5.2. Ownership proportions would usually have been determined in the Collaborative Research Agreement between the parties, pursuant to which the Technology arose.

  • Not all administrative costs will be deducted from Commercialisation Revenue to arrive at the “Net”.

  • The Commercialisation Costs deducted by the University from Commercialisation Revenue to determine Net Revenue include all identifiable out-of-pocket expenses relating to the commercialisation of a particular IP.

  • The determination of whether or not a particular expense should be deducted from Commercialisation Revenue to arrive at the “Net” will be made by the Deputy Vice- Chancellor (Research and Innovation).

  • Any litigation cost, whether incurred during IP registration, infringement or defending an action of infringement, will be deducted from Commercialisation Revenue to arrive at the “Net”.

  • Originators will receive the benefit of the Originators’ share for as long as Commercialisation Revenue is received and upon decease, such benefits will be paid to the Originators’ beneficiaries.

  • Please provide an introduction to your tender setting out why you believe Aberdeen City Council should appoint your firm as our strategic investment adviser.

  • The IP Commercialisation Revenue sharing approach outlined above shall continue to apply after any Creator/Inventor leaves RCSI for other employment or due to retirement.


More Definitions of Commercialisation Revenue

Commercialisation Revenue means (a) royalty upon sale by licensee; (b) royalty from sub-license fees received from a licensee; (c) lump sum license fee;
Sample 1

Related to Commercialisation Revenue

  • Commercialisation means any and all activities directed to the preparation for sale of, offering for sale of, or sale of a product, including activities related to marketing, promoting, distributing, importing and exporting such product. When used as a verb, “to Commercialise” and “Commercialising” means to engage in Commercialization, and “Commercialised” has a corresponding meaning.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Approved Product means any water fitting, plumbing product, material or component which is the subject of an existing WRAS Approval;

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Commercialization Costs means the out-of-pocket costs and expenses incurred by Adapt or its Affiliates directly attributable to, or reasonably allocable to, the Commercialization of a Product. Commercialization Costs for a Product shall include, preparation of promotional, advertising, communication, medical, and educational materials relating to the Product and other Product literature and selling materials, activities directed to marketing of the Product, including purchase of market data, development and conduct of market research, advertising, public relations, public affairs and other communications with Third Parties regarding the Product; development and conduct of sales force training (including materials, programs and travel to and attendance at training programs) for medical representatives responsible for promoting the Product; and development and maintenance of sales bulletins, call reporting and other monitoring/tracking, sales force targeting, validation and alignment programs and documentation.

  • Commercialise means to promote, market, distribute, sell and/or otherwise commercialise a product, and Commercialising and Commercialisation shall be construed accordingly;

  • U.S. Territory means American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Commonwealth of Puerto Rico, or the U.S. Virgin Islands.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Licensed service area means the geographic area in which

  • Net Sales Revenue shall have the meaning as set out in Schedule "A"

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Sublicense Revenues means [***].

  • Net Sales means [***].

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • Sublicense Revenue means [***].

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensed Services means all functions performed by the Licensed System.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.